Microbes and Infectious Diseases (MID)
Journal Descriptions
Microbes and Infectious Diseases is a peer-reviewed, quarterly, open-access journal. It publishes original articles, review articles, short reports, correspondence, and letters to the editor of significant scientific and ethical standards that relate to all fields of medical/clinical/pharmaceutical microbiology, infection prevention and control, and infectious diseases. The scope of the journal includes bacteriology, virology, mycology, parasitology, immunology, epidemiology, and antimicrobial resistance. It also covers clinical and experimental studies on infectious diseases, diagnostic methods, vaccine development, and infection control strategies. The journal encourages interdisciplinary research that integrates laboratory science with clinical practice to improve disease prevention and treatment. With a strong emphasis on global health challenges, the journal addresses emerging and re-emerging infectious diseases, public health concerns, and advances in therapeutic approaches. Its rigorous peer review process ensures the publication of reliable and impactful scientific findings that contribute to the advancement of microbiological and medical knowledge.
Microbes and Infectious Diseases (MID) is :-
-
International, Peer-Reviewed, Open Access, Refereed, Clinical microbiology, Medical microbiology, Infectious Diseases, Infection prevention and control, Antimicrobial resistance, Molecular microbiology, Pharmaceutical Microbiology, Microbial informatics and experimentations, Microbiome, Microbial genetics and Proteomics, bacteriology, virology, mycology, parasitology, immunology, epidemiology, antimicrobial resistance, clinical and experimental studies on infectious diseases, diagnostic methods, vaccine development, infection control strategies , Online or Print , Quarterly Journal
- UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2682-4132, E-ISSN: 2682-4140, Established: 2020,
- Does Not Provide Crossref DOI
-
Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE